| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |